ADA conference preview spotlights newer GLP-1 drugs, research funding cuts and a protest

Elizabeth Cooney reports from the American Diabetes Association annual meeting in New Orleans, introducing the first of three STAT "ADA in 30 Seconds" newsletters. She notes the warm weather outside the conference center and sets the stage for a quick roundup of the most talked‑about topics at the event.

The newsletter highlights three key issues: the arrival of newer GLP-1 therapies, growing pushback against recent cuts to NIH research funding, and a protest that took place during the conference sessions. These items reflect ongoing debates about treatment innovation, research investment, and advocacy within the diabetes community.

Cooney also mentions that the series will continue with additional newsletters, provides a contact email for tips, and reminds readers that full access requires a STAT+ subscription.